SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-002406
Filing Date
2014-08-08
Accepted
2014-08-08 08:33:13
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 405649
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16047
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 4887
  Complete submission text file 0001493152-14-002406.txt   3979912

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20140630.xml EX-101.INS 562185
5 XBRL SCHEMA FILE lixt-20140630.xsd EX-101.SCH 54072
6 XBRL CALCULATION FILE lixt-20140630_cal.xml EX-101.CAL 36232
7 XBRL DEFINITION FILE lixt-20140630_def.xml EX-101.DEF 159290
8 XBRL LABEL FILE lixt-20140630_lab.xml EX-101.LAB 315284
9 XBRL PRESENTATION FILE lixt-20140630_pre.xml EX-101.PRE 217505
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 141025671
SIC: 2834 Pharmaceutical Preparations